Dustin Lee, PharmD helps an 83 years old cannabis-naïve patient with multiple chronic diseases/medications.
Sexual function is comprised of numerous physical and psychological elements that can be measured in both an objective and subjective fashion. Cannabis has long been believed to provide aphrodisiac effects in its users.
Severe chronic or intractable pain of neuropathic origin, or severe chronic or intractable pain is one of the 23 conditions that the Pennsylvania Department of Health has certified as a qualifying condition for medical marijuana use.
The Apothecarium opened its third dispensary in PA. The newly renovated, 5,000 square foot Apothecarium medical dispensary is located at 2701 Lincoln Hwy East, Thorndale, PA.
Through a newly signed agreement, Precision, a Detroit-based company with an extensive portfolio of cannabis extraction, refinement, and processing technologies, will provide state-of-the-art equipment for TerrAscend’s current and future product lines.
Lancaster is getting its very own The Apothecarium medical marijuana dispensary. TerrAscend, a North American operator, bought PA-based Ilera Healthcare last year and has been transitioning their stores into The Apothecarium locations.
TerrAscend Corp., a leading North American cannabis operator, today announced it will open its award-winning The Apothecarium branded dispensaries in two Pennsylvania locations; one in Lancaster and a second in Plymouth Meeting.
Ilhera was named favorite Pennsylvania Medical Marijuana Brand by Compassionate Certification Centers – Their research evaluated thousands of subjects who are current or past participants in the Pennsylvania Medical Marijuana Program who were asked to answer a variety of questions based on their first-hand experience.
Medical cannabis healthcare network and collaborators are pleased to announce the conclusion and publication of a medical marijuana focused observational study in Pennsylvania.
Cannabis naïve patients just starting out should begin with micro-dosing of their medication. Micro-dosing is defined as the administration of doses so low that they are unlikely to produce a whole-body effect, but high enough to allow a cellular response.